Corbus Pharmaceuticals Holdings (CRBP) Research & Development (2013 - 2025)

Corbus Pharmaceuticals Holdings' Research & Development history runs 13 years deep, the most recent figure standing at $20.9 million for Q3 2025.

• In Q3 2025, Research & Development rose 93.01% year-over-year to $20.9 million; the TTM figure through Sep 2025 stood at $60.5 million (up 98.84% YoY), while the FY2024 annual figure was $32.2 million, up 3.38% from the prior year.
• Research & Development was $20.9 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $15.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $20.9 million in Q3 2025 to a low of $380000.0 in Q4 2021.
• Historically, Research & Development has averaged $8.5 million across 5 years, with a median of $7.0 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Research & Development tumbled 97.64% in 2021, then jumped 1542.83% in 2022.
• A 5-year view of Research & Development shows it stood at $380000.0 in 2021, then surged by 1542.83% to $6.2 million in 2022, then increased by 11.81% to $7.0 million in 2023, then advanced by 25.89% to $8.8 million in 2024, then surged by 137.4% to $20.9 million in 2025.
• The last three Research & Development figures came in at $20.9 million (Q3 2025), $15.2 million (Q2 2025), and $15.6 million (Q1 2025), per Business Quant data.